Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (261-270 of 721) with videos related to

Pageof 73
Sort By:
Seminars in Nuclear Medicine|September 27, 2025
Nectin-4, Bladder Cancer, and Nuclear Medicine: A Theranostic FrontierJoseph Kabunda, Honest Ndlovu, Karishma Singh, et al.
Annals of Nuclear Medicine|March 12, 2025
FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer?Irene García Megías, Ludmila Santiago Almeida, Adriana K Calapaquí Terán, et al.
Scientific Reports|December 3, 2017
Whitening and Impaired Glucose Utilization of Brown Adipose Tissue in a Rat Model of Type 2 Diabetes MellitusConstantin Lapa, Paula Arias-Loza, Nobuyuki Hayakawa, et al.
The Lancet. Oncology|March 6, 2020
Radiotheranostics: a roadmap for future developmentKen Herrmann, Markus Schwaiger, Jason S Lewis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 3, 2019
Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trialMaja Guberina, Wilfried Eberhardt, Martin Stuschke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 1, 2014
Intraoperative 3-D imaging improves sentinel lymph node biopsy in oral cancerChristina Bluemel, Ken Herrmann, Alexander Kübler, et al.
Oncotarget|March 4, 2016
Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapyConstantin Lapa, Heribert Hänscheid, Vanessa Wild, et al.
European Urology Oncology|March 22, 2021
Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment: A Systematic ReviewAndrea Farolfi, Boris Hadaschik, Freddie C Hamdy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2024
Diagnostic Accuracy of [<sup>18</sup>F]FDG PET/MRI in Head and Neck Squamous Cell Carcinoma: A Systematic Review and MetaanalysisAkram Al-Ibraheem, Ahmed Abdlkadir, Ken Herrmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2006
Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junctionKatja Ott, Wolfgang A Weber, Florian Lordick, et al.
Pageof 73

Showing results (261-270 of 721) with videos related to

Sort By:
Pageof 73
Seminars in Nuclear Medicine|September 27, 2025
Nectin-4, Bladder Cancer, and Nuclear Medicine: A Theranostic FrontierJoseph Kabunda, Honest Ndlovu, Karishma Singh, et al.
Annals of Nuclear Medicine|March 12, 2025
FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer?Irene García Megías, Ludmila Santiago Almeida, Adriana K Calapaquí Terán, et al.
Scientific Reports|December 3, 2017
Whitening and Impaired Glucose Utilization of Brown Adipose Tissue in a Rat Model of Type 2 Diabetes MellitusConstantin Lapa, Paula Arias-Loza, Nobuyuki Hayakawa, et al.
The Lancet. Oncology|March 6, 2020
Radiotheranostics: a roadmap for future developmentKen Herrmann, Markus Schwaiger, Jason S Lewis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 3, 2019
Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trialMaja Guberina, Wilfried Eberhardt, Martin Stuschke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 1, 2014
Intraoperative 3-D imaging improves sentinel lymph node biopsy in oral cancerChristina Bluemel, Ken Herrmann, Alexander Kübler, et al.
Oncotarget|March 4, 2016
Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapyConstantin Lapa, Heribert Hänscheid, Vanessa Wild, et al.
European Urology Oncology|March 22, 2021
Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment: A Systematic ReviewAndrea Farolfi, Boris Hadaschik, Freddie C Hamdy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2024
Diagnostic Accuracy of [<sup>18</sup>F]FDG PET/MRI in Head and Neck Squamous Cell Carcinoma: A Systematic Review and MetaanalysisAkram Al-Ibraheem, Ahmed Abdlkadir, Ken Herrmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2006
Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junctionKatja Ott, Wolfgang A Weber, Florian Lordick, et al.
Pageof 73